Construction and Immunogenicity Evaluation of Recombinant Bacillus subtilis Expressing HA1 Protein of H9N2 Avian Influenza Virus

This study was the first to use an oral recombinant B. subtilis-HA1 vaccine candidate, and it provides theoretical data and technical reference for the creation of a new live vector vaccine against H9N2 AIV.PMID:38040977 | DOI:10.1007/s00284-023-03548-x

Source: Current Microbiology - December 1, 2023 Category: Microbiology Authors: Zixuan Li Chong Peng Lijun Chen Peng Wang Fangkun Wang Source Type: research